Introduction
Arterial stiffening is the major cause of increasing systolic pressure with advancing years and in patients with arterial hypertension. 1 Elevated aortic stiffness induces high systolic blood pressure (SBP), augmented pulse pressure (PP) with increased ventricular afterload and augmented pulsatile stress in peripheral arteries. 2, 3 Hypertension, in turn, negatively influences stiffness of the aorta and large arteries. 4 The pathogenesis of hypertension is characterized by a strong genetic background. 5 Recently a C825T polymorphism was identified in the GNB3 gene encoding the G protein b3 subunit, 6 and an association of the T-allele with hypertension has been found in several studies. [6] [7] [8] [9] [10] Carriers of the T-allele exhibit an augmented response to several antihypertensive drug regimes. 11, 12 The mechanisms linking the presence of the T-allele to the development of hypertension in later life are, however, unclear.
The purpose of the present study was to evaluate the effect of the C825T polymorphism on arterial stiffness. Arterial stiffness was assessed using pulse wave velocity (PWV), the classical parameter, 13 and pulse wave analysis, a recently developed technique that determines the effect of pulse wave reflection on the central aortic pressure configuration. 14, 15 We studied this potential association in a population of young, healthy males to minimize potential contributions of age, 14,16 gender 17,18 or disease 4 to the stiffness determinants.
Materials and methods

Study population and protocol
The study population included 99 young, male volunteers who gave informed, written consent.
Only male subjects were selected because augmentation index has been shown to differ between male and female subjects. 17, 18 All subjects were drug-free and judged to be healthy on the basis of medical history, physical examination, electrocardiogram and routine laboratory screening. DNA extraction from whole blood and genotyping for the GNB3 C825T polymorphism were performed as previously described. 6 The study was approved by the Ethics Committee of the University of Essen Medical School and was in accordance with the principles laid down in the Declaration of Helsinki.
Measurements were performed in a quiet, temperature-controlled (241C) room. On the study day, volunteers reported to the laboratory at 0700-0800 after an overnight fast to eliminate postprandial haemodynamic changes. During the investigation, subjects remained in the supine position. After a period of 30 min of complete rest, haemodynamic measurements were performed.
Anthropometric and haemodynamic parameters
Height and weight were measured and body mass index (BMI) was calculated as weight to height squared. Blood pressure (mmHg) was measured with a standard mercury sphygmomanometer with the disappearance of Korotkow's sound defined as diastolic blood pressure (DBP). PP was calculated by subtracting DBP from SBP.
Pulse transmission time (ms) was determined noninvasively from pressure tracings over the carotid and femoral artery which were recorded using a Siemens-Cardirex s multichannel ink jet recorder (Siemens Medizintechnik, Erlangen, Germany) as previously described. 16 Briefly, anatomical measurements of the distance between the carotid and femoral artery were made on the surface of the body. The distance between carotid artery recording site and the suprasternal notch was subtracted from the distance from the suprasternal notch over the the umbilicus to the femoral artery recording site. PWV (m/s) was calculated as the ratio between the distance travelled by the pulse wave and pulse transmission time. 19 Pulse wave analysis was performed in 72 subjects (CC, n ¼ 30; TC&TT, n ¼ 42), as previously described by our laboratory. 16, 20 Central haemodynamics were calculated from radial pulse waves that were recorded by applanation tonometry.
14 Data were collected directly into a portable computer; integral software was used to generate an averaged peripheral waveform (SphygmoCor, PWV Medical, Sydney, Australia). From the peripheral recordings, the central arterial pressure was derived with the use of a generalized transfer function that has been shown to give an accurate estimate of the central arterial pressure waveform. 15, 21 The systolic part of the central arterial waveform is characterized by two pressure peaks. The first peak is caused by left ventricular ejection, whereas the second peak is a result of wave reflection. Augmentation index (%) is calculated from augmentation divided by pulse pressure expressed as a percentage and reflects the degree to which central arterial pressure is augmented by wave reflection. 14 
Statistical analysis
Based on population studies, 6, [8] [9] [10] 22 our hypothesis was that the presence of the 825T-allele (homozygous or heterozygous) would influence markers of arterial stiffness relative to subjects of the CC genotype. Therefore, statistical comparisons were used to determine the significance of differences between 825T-allele carriers and subjects of the CC genotype by unpaired t-tests, that is, TC and TT subjects were pooled for analyses. Moreover, the TT genotype is relatively rare in Caucasian subjects. 10 Hence, in studies into which subjects are randomly included we expect not more than 10% homozygous 825T-allele carriers.
Linear regression analysis was performed to identify parameters known to affect arterial stiffness including age, cholesterol and smoking. PWV and Augmentation index were corrected for those parameters found to be significantly correlated to PWV or augmentation index.
Po0.05 was considered statistically significant. All values are shown as mean 7 s.e.m. Statistical analysis was performed using GraphPad Prism 3.0 for MS Windows (GraphPad Software, Inc., San Diego, CA, USA).
Results
Subject characteristics by genotype are displayed in Table 1 . There was no significant difference between 825T-allele carriers and subjects of the CC genotype regarding anthropometric or metabolic parameters, family history of hypertension, smoking or peripheral blood pressure. Carriers of the T-allele showed a lower heart rate, but this difference failed to reach statistical significance (P ¼ 0.0727). Table 2 shows the markers of arterial stiffness and central arterial haemodynamics. Carriers of the 825T-allele exhibited a significantly higher PWV compared to subjects with the homozygous CC genotype (6.0 7 0.1 m/s (TC&TT) vs 5.7 7 0.1 m/s (CC); P ¼ 0.0251) (Figure 1 ). This difference became more significant, when PWV was corrected for heart rate (P=0.0038).
There was also a significant difference (P ¼ 0.0448) in augmentation index between carriers of the T-allele (CT&TT: 3.4 7 2.9%) and controls with the CC genotype (À5.0 7 4.1%) (Figure 2 ). Similar to PWV, the difference in augmentation index between both groups reached greater statis-tical significance when augmentation index was corrected for heart rate (P=0.0054).
We found that both PWV (P ¼ 0.0012) and augmentation index (P ¼ 0.0133) were correlated to age (Po0.05), but not to cholesterol, smoking or family history of hypertension. When corrected for age, augmentation index (P ¼ 0.0067) and PWV (P ¼ 0.0269) remained significantly different between the two study groups.
There was no difference in aortic SBP or DBP, or aortic PP between the two groups.
Discussion
Stiffening of the arterial wall is an inevitable process that occurs during aging and is accelerated in cardiovascular disease including hypertension. 14 Increased arterial stiffness is one major mechanism responsible for morbidity and mortality in cardiovascular disease including hypertension. 23 In order to further explore a possible pathogenetic link between arterial stiffness and the development of hypertension, we have compared two indices of arterial stiffness in young, healthy, normotensive, nonobese men with and without the 825T-allele. We found that both stiffness markers were significantly increased in young carriers of the Tallele while there was no difference in blood pressure. This difference remained statistically significant after PWV and augmentation index were corrected for age. These findings support the hypothesis that arterial stiffening may pathogenetically contribute to the development of hypertension in carriers of the T-allele. This study also supports the idea that stiffening of large arteries may be influenced by genetic factors, 24 and is not just a mere consequence of aging or the presence of cardiovascular disease. Similar to other genes of the cardiovascular system including endothelin gene variants, 25 an influence of the C825T polymorphism may first be detected in arterial parameters. In the light of the extensive use of association studies, identifying and characterizing physiological relationships is needed to validate the potential relevance of gene polymorphisms. 26 This is the first study elucidating a potential association between the 825T-allele and arterial stiffening.
Interestingly, T-allele carriers exhibited a lower heart rate, even though this difference did not reach statistical significance. It is possible that higher afterload in T-allele carriers reflected by higher PWV and augmentation index may negatively influence heart rate by baroreflex activation.
In a recent cross-sectional study, Brand et al 27 found that middle-aged male TT homozygotes have a higher blood pressure than C-allele carriers. In contrast, in this study we did not find a significant difference in blood pressure between T-allele carriers and controls in a population of young, healthy males. This lack of association between the T-allele and blood pressure in young people could be explained on the basis of aortic pressure amplification. In the elderly, the reflected pulse wave returns to the aorta in the systole, thereby increasing SBP and PP. In contrast, in younger subjects, the reflected pulse wave returns during the diastole due to a lower PWV. 28 Thus, the phenomenon of wave reflection may contribute to the finding that an association between male T-allele carriers and blood pressure can be observed in older individuals but not in younger subjects.
We and others have shown that DBP is a major determinant of PWV and augmentation index in young, healthy males. 16 In this study, DBP was identical between genotypes. Therefore, the observed differences in PWV and augmentation index cannot be attributed to differences in blood pressure.
In this study, we used two methods to estimate arterial stiffness. First, we determined PWV, a traditional measure, 13 that has been shown to predict cardiovascular mortality in patients with essential hypertension and chronic renal failure. 29, 30 To date, PWV constitutes one of the most widely used and robust surrogates of arterial stiffness. Second, we employed pulse wave analysis, a recently developed technique, that offers a simple way to measure arterial function. 14, 15 Pulse waves are recorded at a single conveniently exposed artery, such as the radial artery, and used to calculate augmentation index, a measure that reflects the degree to which central arterial pressure is enhanced by wave reflection of the pulse wave. 14, 15 This new technique is reproducible, noninvasive and increasingly used in clinical studies. 31, 32 Both measures are closely correlated, 16, 33 and PWV is an important determinant of augmentation index. However, both measures were derived using methods that are technically completely independent from each other. Thus the association of both indices with the T-allele further strengthens the validity of this finding.
Indices of arterial stiffness may be influenced by several anthropometric and haemodynamic factors such as blood pressure, heart rate and BMI. 16, 18 Furthermore, the evaluation of stiffness markers is complicated by age-related changes in the vasculature including widening of pulse pressure, 34 changes in heart rate, blood pressure and vascular resistance. 35 Therefore, we chose to study a homogeneous population of young, healthy males in the absence of any contribution of age, gender or disease-related changes of the vasculature. However, further studies are needed to characterize the impact of the C825T polymorphisms on arterial stiffness in other populations including female and older subjects.
In summary, in a study population of young, healthy males, carriers of the T-allele exhibited a higher arterial stiffness compared to controls with the CC genotype. It is possible that arterial stiffening may pathogenetically contribute to the development of hypertension in carriers of the T-allele.
